Clare&me is a technology company.
Clare&me has raised $5.2M across 3 funding rounds.
Clare&me has raised $5.2M in total across 3 funding rounds.
Clare&me has raised $5.2M in total across 3 funding rounds.
Clare&me's investors include Antler, Atomico, Seraphim Space, Sunfish Partners, Anna Alex, Jan Wilmking, Travis Todd.
clare&me is a Berlin-based healthtech startup founded in 2021 that develops a voice-based AI assistant named "Clare" for mental health support, delivering clinically proven behavioral therapy techniques via smartphones.[1][2][3] It serves individuals facing anxiety, depression, and related issues—primarily ages 35-45 but appealing to younger users—by addressing therapist shortages, long wait times (up to 18 months in some regions), high costs, and therapy stigma through accessible, 45-minute sessions on WhatsApp or phone calls.[1][2] The company has raised €3.7M in Series A funding led by YZR, with backing from Kodori Ventures, Material Ventures, European Investment Fund, and others, fueling product development and ethical AI enhancements amid growing mental health demand.[1][2][5]
clare&me was co-founded in 2021 by Emilia Theye (Co-CEO, expert in business, psychology, and conversation design) and Celina Messner (Co-CEO, ex-Google product and tech executive).[1][2][3] The idea emerged from the founders' recognition of global mental health crises, including therapist scarcity (e.g., only 4% annual capacity growth) and surging demand like 11% referral increases in UK services.[1][2] Early traction built on voice AI's human-like interaction, with the female-led team prioritizing ethical safeguards from inception; pivotal funding in 2024 validated their approach, enabling Europe-wide expansion.[2]
clare&me rides the AI-healthtech wave, capitalizing on post-pandemic mental health surges and therapist shortages amid Europe's innovation push (e.g., EIF backing).[1][2] Timing aligns with voice AI maturity and regulatory tailwinds like GDPR, enabling ethical scaling where human resources lag; market forces include rising referrals and demand for affordable, 24/7 care.[2] It influences the ecosystem by redefining AI-human therapy hybrids, inspiring privacy-first models, and bridging healthtech with conversational AI, potentially accelerating adoption in underserved regions.[2][6]
With €3.7M fueling clinical AI advancements, clare&me is poised for pan-European growth, deeper research integration, and potential U.S. entry via HIPAA compliance.[2][5][6] Trends like multimodal AI and personalized behavioral health will shape its path, amplifying impact as shortages persist; its ethical stance could evolve it into a category leader, influencing standards for compassionate AI in wellness.[2] This positions clare&me to transform accessible therapy from niche to essential, echoing its founding mission to democratize mental health support.[1]
Clare&me has raised $5.2M across 3 funding rounds. Most recently, it raised $4.0M Seed in August 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 1, 2024 | $4.0M Seed | Antler, Atomico, Seraphim Space, Sunfish Partners, Anna Alex, Jan Wilmking, Travis Todd | |
| Feb 1, 2022 | $1.0M Seed | Antler, Atomico, Travis Todd | |
| Sep 1, 2021 | $200K Seed | Antler, Atomico, Seraphim Space, Sunfish Partners, Anna Alex, Jan Wilmking, Travis Todd |